Table 1.
Age distribution of the patients with E30-positive samples
Age group (years) | Total no. of patients investigated | E30-positive patients n (%) | Negative patients n (%) |
---|---|---|---|
0–4 | 26 | 11 (42·3) | 15 (57·7) |
5–9 | 58 | 47 (81·0) | 11 (19·0) |
10–14 | 43 | 35 (81·4) | 8 (18·6) |
>15 | 30 | 24 (80·0) | 6 (20·0) |